How long does resistance to Dasatinib usually last?

Dasatinib (Dasatinib) is a targeted drug commonly used to treat certain leukemias (such as chronic myelogenous leukemia, or acute lymphoblastic leukemia). The rate at which resistance develops varies among individuals and there is no set time. Generally, in the early stages of treatment with dasatinib, the drug can effectively control the growth and spread of leukemia cells. However, over time, some leukemia cells may develop resistance to dasatinib, causing the drug to become ineffective. The development of resistance can take months or even years, depending on individual patient differences, type of disease, and other influencing factors.